Disorder of Glucose Regulation Clinical Trial
Official title:
Glucerna in Critically Ill Patients (GluCip Trial): Investigating the Glycaemic Effects of a Reduced-carbohydrate, Modified-fat, Fiber-containing Enteral Formula (Glucerna®) in Critically Ill Patients.
To investigate whether the administration of Glucerna achieves less glycaemic variability, defined as the mean absolute glucose (MAG) change, and better glycaemic control compared to a standard high-carbohydrate enteral formula. Continuous glucose monitoring technology will be used to evaluate glycaemic variability and glycaemic control.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01856907 -
Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
|
Phase 4 | |
| Completed |
NCT03352869 -
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
|
Phase 4 | |
| Completed |
NCT02022007 -
Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
|
Phase 3 | |
| Completed |
NCT02219295 -
SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition
|
N/A | |
| Completed |
NCT01234649 -
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
|
Phase 3 |